Nucleate Australia - From Molecule to Market: Navigating IP in Biotech Innovation

Nucleate PATH: Policy From Molecule to Market: Navigating IP in Biotech Innovation Nucleate Australia is excited to partner with GLMR and Sydney Knowledge Hub to host our upcoming event on the role of intellectual property in biotech. In biotechnology, great science is only one part of the journey. Understanding how to protect, manage, and translate intellectual property is essential for anyone interested in commercialisation and innovation. Join us for an evening exploring the role of intellectual property in biotechnology and gain insights from leaders across innovation, investment, commercialisation, and entrepreneurship. This evening will explore: Protecting and translating biotech discoveries. What investors look for in early-stage biotech IP. University commercialisation pathways. Founder insights on IP, fundraising, and startup growth. Speakers: Melissa Erce - GLMR, Senior Associate, Registered Patent Attorney Jenna Enmon - GLMR, Special Counsel, Registered Patent Attorney, Registered Trade Mark Attorney Emma-Louise Hunsley - University of Sydney, Commercialisation Manager, Sydney Biomedical Accelerator Edward Yang - Aurelion Scientific, CEO & co-founder Alexandra Mahoney - Uniseed, Investment Analyst Join us, 📅 Wednesday, 26th August 2026 ⏰ 5:30 pm - 8:00 pm (event starts at 6 pm) 📍 Sydney Knowledge Hub, Level 2, Merewether Building, University of Sydney We thank GLMR and Sydney Knowledge Hub for partnering with us on this event! We extend our appreciation to the sponsors and partners who directly support the Nucleate Australia chapter. Their commitment strengthens our mission to empower emerging founders and expand the biotech innovation ecosystem across the state. Their contributions help create the open-access programming, community events, and founder support that make Nucleate Australia possible. Chapter Sponsors: University of Melbourne, Monash University, CSL, Sydney Knowledge Hub, GLMR About the Host: Nucleate is a 501(c)(3) nonprofit organization dedicated to empowering the next generation of biotech leaders. With chapters spanning 41 geographic regions and participation from over 280 academic institutions, Nucleate sparks new intellectual communities and embeds emerging talent within a global biotech community. Through open-access educational programming, Nucleate helps democratize biotech innovation — removing barriers and helping founders concentrate on building transformational technologies. Visit www.nucleate.xyz for more information, and visit https://nucleate.xyz/privacy-policy/ to read our privacy policy. We want to thank our HQ supporters for championing our open-access mission and empowering the next generation of biotech entrepreneurs! Platinum: Eli Lilly and Company, Genentech, Alnylam Pharmaceuticals, MilliporeSigma Philanthropic Support: Lyda Hill Philanthropies Preferred Partners: Pillar VC, Amino Collective, Excedr, Mercury, Brex, Fedsprout In-Kind Support: AcademicLabs, Lens.org, SynBioBeta